Ascendiac

Excella Pharmaceutical's ground-breaking diet drug, Ascendiac, is in the midst of the FDA's final phase of testing when volunteer subjects begin mysteriously dropping out of the study. The drug's inventor, Dr. Jack Finnegan, starts investigating the new developments, only find himself dangerously mired in a twisted maze of greed, deceit, and organized crime. With patients and profits suddenly at grave risk, his only hope lies in a cutting-edge clinical psychiatrist, Alison Sonders, MD, who helps him unravel the complex relationship between overeating, mood, and dieting in this fast-paced medical thriller.